Brokerages Set Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Price Target at $60.56
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty ratings firms that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, six have given a hold rating, twelve have assigned a buy rating and one […]
More Stories
UN officials remember brutal 7 October attacks, reiterate need for peace
Senior officials from across the UN system underscored the need for peace between Israelis and Palestinians, and across the wider...
News from the WHO: Types of data requested to inform December 2024 COVID-19 vaccine antigen composition deliberations https://ift.tt/NUaBW5H October 07, 2024 at 07:00AM
Published on October 07, 2024 at 07:00AM View on website
‘It’s Our Hurricane Katrina’: Asheville Residents Describe Death, Destruction, Danger After Hurricane Helene
By Arjun Singh ASHEVILLE. N.C.—Tunnel Road is a major thoroughfare between Asheville and the Swannanoa Valley in western North Carolina....
California Faces Wave of Lawsuits Over Gender Identity Notification in Schools
By Brad Jones A mother’s tears of worry and frustration over her 17-year-old daughter’s secret social gender transition at school...
Lennar Co. (LEN) to Issue Quarterly Dividend of $0.50 on October 24th
Lennar Co. (NYSE:LEN – Get Free Report) announced a quarterly dividend on Wednesday, September 25th, NASDAQ reports. Shareholders of record...
Industria de Diseño Textil, S.A. (OTCMKTS:IDEXY) Plans Dividend of $0.29
Industria de Diseño Textil, S.A. (OTCMKTS:IDEXY – Get Free Report) announced a dividend on Saturday, October 5th, NASDAQ reports. Investors...